Source: Eur Respir J 2012; 39: 1144-1155
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Bello Salvador, Lasierra Ana B., Mincholé Elisa, Fandos Sergio, Ruiz Maria Angeles, Vera Elisabeth, de Pablo Francisco, Ferrer Miguel, Menendez Rosario, Torres Antoni. Prognostic power of proadrenomedullin in community-acquired pneumonia is independent of aetiology. Eur Respir J 2012; 39: 1144-1155

Member's Comments

No comment yet.

Related content which might interest you: MR-proANP and prognosis of ventilator-associated pneumonia Source: Annual Congress 2009 - Ventilator-associated pneumonia, severe community-acquired pneumonia and healthcare associated pneumonia Year: 2009 Pro-atrial natriuretic peptide and pro-vasopressin to predict severity and prognosis in community-acquired pneumonia Source: Eur Respir J 2007; 30: Suppl. 51, 481s Year: 2007 Prognostic factors of mortality in patients with community-acquired pneumonia (CAP) Source: Eur Respir J 2003; 22: Suppl. 45, 239s Year: 2003 Biomarkers for the prognostic assessment and disease severity evaluation in community-acquired pneumonia (CAP) Source: Annual Congress 2010 - The prognosis of community-acquired pneumonia: old and new markers of severity Year: 2010 Pro-adrenomedullin, pro-atrial natriuretic peptide and procalcitonin levels at admission in patients with community-acquired pneumonia and its correlation with risk scores Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia Year: 2011 Copeptin and prognosis of ventilator-associated pneumonia Source: Annual Congress 2008 - Features of hospital-acquired pneumonia, ventilator-associated pneumonia and infection with other pathogens Year: 2008 Role of procalcitonin in predicting severity and in-hospital mortality in patients with community-acquired pneumonia Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues Year: 2016 Management-based risk prediction in community-acquired pneumonia by scores and biomarkers Source: Eur Respir J 2013; 41: 974-984 Year: 2013 Diagnostic and prognostic utility of procalcitonin (PCT) measurements in patients with hospitalized community-acquired pneumonia (CAP) Source: Annual Congress 2009 - Assessment of severity in respiratory infections: severity scales and biomarkers Year: 2009 Copeptin application in severe community-acquired pneumonia (SCAP) severity assessment and outcomes Source: Annual Congress 2012 - Respiratory infections: a clinical point of view Year: 2012 Value of bacteraemia as an unfavourable prognostic factor for community-acquired pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 350s Year: 2006 Diagnostic and prognostic value of C-reactive protein in community-acquired pneumonia hospitalized patients Source: Eur Respir J 2004; 24: Suppl. 48, 188s Year: 2004 The assessment of prognostic rules in patients with community-acquired pneumonia (CAP) Source: Eur Respir J 2003; 22: Suppl. 45, 149s Year: 2003 Biomarkers and severity in community-acquired pneumonia (CAP) Source: Annual Congress 2012 - Prognostic indices in respiratory infections Year: 2012 Midregional pro-atrial natriuretic peptide and procalcitonin improve survival prediction in VAP Source: Eur Respir J 2011; 37: 595-603 Year: 2011 Prognostic value of procalcitonin in community-acquired pneumonia Source: Eur Respir J 2011; 37: 384 Year: 2011 Procalcitonin as etiological marker of severe community-acquired pneumonia Source: Annual Congress 2013 –Interesting cases of respiratory infections Year: 2013 Prognostic value of plasma D-dimer level in adults with community-acquired pneumonia – A prospective study Source: International Congress 2015 – CAP: prognostic factors in frail patients Year: 2015 Predictive and prognostic factors in patients with blood-culture-positive community-acquired pneumococcal pneumonia Source: Eur Respir J 2016; 48: 797-807 Year: 2016 Procalcitonin and D-dimer to predict prognosis and clinical outcomes in severe community-acquired pneumonia (SCAP) patients Source: Annual Congress 2012 - Respiratory infections: a clinical point of view Year: 2012